Osimertinib (CAS: 1421373-65-0)

Short Description:

API’s Name Indication Innovator Patent Expiry Date(The U.S)
Osimertinib NSCLC AstraZeneca  Aug.8,2032


Product Detail

Product Tags


  • Previous:
  • Next:

  • Write your message here and send it to us

    Products categories